☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Verastem Oncology
Verastem Oncology’s Avutometinib Gains the US FDA’s Orphan Drug Designation to Treat Pancreatic Cancer
July 30, 2024
Verastem Oncology Entered into a Discovery and Development Collaboration with GenFleet to Advance Three Programs Targeting RAS Pat...
August 29, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.